RELX · Analysis updated Nov 10, 2026, 6:00 PM ET

Why is RELX PLC (RELX) stock moving?

RELX closed at 39.91 on Nov 10, about 1.7% below the 40.62 close on Oct 22, and it has traded between 38.73 and 41.45 over the last 30 days. The sharpest move came on Nov 4 to Nov 5, when the stock rose to a 41.45 close on 3.6M shares. It then gave back those gains on falling volume, closing at 40.17 on Nov 6 and around 39.9 by Nov 10 on 1.58M shares, which suggests fading momentum. The main fundamental news is the Oct 22 trading update: underlying revenue growth of +7% year to date, with Legal +10%, Risk +8% and STM +6%. RELX reaffirmed its full-year outlook and expects adjusted operating profit growth to exceed revenue growth. Bernstein raised its price target and kept an Outperform rating on Oct 28. The company is also buying back its own shares, with 697,106 bought for about £20.68 million in the week of Oct 26 to Oct 30, which adds steady demand. The product news (Know Your Agent, Accurint One, the Elsevier report) is incremental and not quantified, and the block share admission is routine. The data gives no quarterly figures or new guidance numbers, and the price is now below its late-October level, so the near-term view is balanced while the medium-term view leans positive.

News behind the analysis

About RELX PLC

Industrials · Information services and analytics

RELX is a UK-based global provider of data, analytics and decision tools for professional and business customers, with its ADR traded on the NYSE. It is known for brands such as LexisNexis (legal and risk) and Elsevier (scientific publishing), and most of its revenue comes from subscriptions and repeat use. Its adjusted operating margin is high, around 35% in the first half of 2026.

How it makes money

RELX has four segments. Risk (LexisNexis Risk Solutions) sells fraud, identity and credit-risk analytics and brings in roughly a third of revenue. Scientific, Technical & Medical (Elsevier) sells journals, databases and research tools, also about a third. Legal (LexisNexis Legal & Professional) sells legal research and AI-assisted tools, about a fifth. Exhibitions (RX) runs trade shows, roughly a sixth. Total revenue was about £9.6bn in 2025. In the first half of 2026 revenue was about £4.9bn, with roughly 7% underlying growth.

What usually moves RELX

Similar companies

TRI, WKL, SPGI, MCO, VRSK

All stock analyses · Stock market today

This analysis is for informational purposes only and is not investment advice. It is based solely on the news items, SEC filings and market data provided, and past price behavior does not guarantee future results.